Top Quality 99% Anti-Ulcer CAS 90098-04-7 Rebamipide
GMP HALAL KOSHER ISO FDA 7 Inquiries
90098-04-7
Pharmaceutical Grade
0%
Foil Bag, Box, Drum
2022-12-31
Herb Extracts,Cosmetic raw materails,API
-
Product Description
-
Seller Information
-
Inquiry History
-
Description
Pr oduct name: Rebamipide Other Name (+-)-1,2-dihydro-alpha-((4-chlorobenzoyl)amino)-2-oxo-4-quinolinepropanoica;(+-)-2-(4-chlorobenzoylamino)-3-(2(1h)-quinolinon-4-yl)propionicacid;1,2-dihydro-alpha-((4-chlorobenzoyl)amino)-2-oxo-4-quinolinepropanoicaci(;2-dihydro-alpha-((4-chlorobenzoyl)amino)-2-oxo-(+-)-4-quinolinepropanoicaci;opc12759;opc-12759;Rebamipid;REBAMIPIDE Original Made-In-China CAS 90098-04-7 Molecular formula C19H15ClN2O4 Appearance White Powder Certification SGS, ISO 9001, KOSHER Payment Terms Western Union, Money Gram , T/T, Bitcoin Minimum Order Quantity 10 g Price Negotiable Usage It is used for treating stomach ulcers. Delivery Fast and secure shipping by EMS, DHL, TNT, FedEx, UPS Prevents and treatment of injury of gastric mucosal caused by NSAIDs
Rebamipide has an obvious reversal effect on the side effects of NSAIDs drug-induced reduction of the synthesis of gastric mucosal prostaglandin and increased permeability of mucosa. Further study has found that patients taking NSAIDs had gotten high expression of gastric epithelial HIF-1, suggesting that the gastric mucosa of patients is within the hypoxic-ischemic state; However, patients taking rebamipide has significantly reduced HIF-1 expression, demonstrating that rebamipide has a very good protective effect on the gastric mucosa of patients taking NSAIDs table. From this perspective, rebamipide may have a prevention and treatment effect on NSAIDs (especially non-selective NSAIDs) induced gastric mucosal damage.
HP-related gastritis treatment
Rebamipide,Haruma et al have reported that: in the observation of clinical treatment of 86 HP-positive patients, 53 patients taking rebamipide had stomach antrum and stomach body monocytes with significant reduction on granulocytes cell infiltration and had the stomach inflammation much more be alleviated than those without medication, indicating that it has a high-quality effect on treating HP-associated gastritis.
COA
Product Rebamipide Test items Standard Results Appearance White crystalline powder, bitter taste White crystalline Melting point About 291ºC(decomposition) Conforms Identification Conforms 290ºC Loss on drying ≤3.0% Conforms Sulphated ash ≤0.10% 1.0% Assay 99.0%~101.0% 99.2% Conclusion The above product conforms to JP6 standard 
CertificatesBasic Info-
Product Name:
Rebamipide
Other Name:4-Quinolinepropanoic acid,α-[(4-chlorobenzoyl)amino]-1,2-dihydro-2-oxo-;α-[(4-Chlorobenzoyl)amino]-1,2-dihydro-2-oxo-4-quinolinepropanoic acid;OPC 12759;Proamipide;Rebamipide;Mucosta;Rebator;2-(4-Chloro-benzoylamino)-3-(2-hydroxy-quinolin-4-yl)-propionic acid;2-(4-Chloro-benzoylamino)-3-(2-oxo-1,2-dihydro-quinolin-4-yl)-propionic acid;2-[(4-Chlorobenzoyl)amino]-3-(2-oxo-1H-quinolin-4-yl)propanoic acid;111911-87-6;139344-42-6
CAS No.:90098-04-7
Molecular Formula:C19H15ClN2O4
InChIKeys:InChIKey=ALLWOAVDORUJLA-UHFFFAOYSA-N
Molecular Weight:370.78600
Exact Mass:370.79
NSC Number:758955
DSSTox ID:DTXSID8045937
ATC Code:A - Alimentary tract and metabolism
HScode:2933790090
Categories:
Characteristics-
PSA:
99.26000
XLogP3:2.4
Appearance:White Powder
Density:1.394 g/cm3
Melting Point:248-257 °C (decomp)
Boiling Point:695ºC at 760 mmHg
Flash Point:374.1ºC
Refractive Index:1.634
Storage Conditions:Store in original container in a cool dark place.
Vapor Pressure:2.83E-20mmHg at 25°C
Collision Cross Section:185 Ų [M+H]+ [CCS Type: TW, Method: calibrated with polyalanine and drug standards]
Hazard IdentificationClassification of the substance or mixture
no data available
GHS label elements, including precautionary statements
Pictogram(s) no data available Signal word no data available
Hazard statement(s) no data available
Precautionary statement(s) Prevention no data available
Response no data available
Storage no data available
Disposal no data available
Other hazards which do not result in classification
no data available
Handling and StoragePrecautions for safe handling
Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.
Conditions for safe storage, including any incompatibilities
Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.
-
-
Seller Information
-
Business Type:
Manufactory
-
Main Products:
Herb Extracts,Cosmetic raw materails,API
-
Location:
1403,Jinye B Block
-
Payment Terms:
TT against copy of documents
-
Average lead Time:
8
-
Total Annual Revenue:
$2.5 million-$5 million
-
Total Employees:
11-50
-
Year of Establishment:
2015
-
-
Inquiry History7 Inquiries
Country Product Purchase Quantity Date Posted 
India
REBAMIPIDE
1 KG May 12, 2025
India
Rebamipide Ophthalmic 2%
30 PCS Jun 22, 2026
India
REBAMIPIDE
10 G Nov 24, 2025
India
Rebamipide
1 G Sep 10, 2025 
Austria
Rebamipide
5 KG Aug 12, 2025
India
Rebamipide
500 KG Feb 24, 2026
India
REBAMIPIDE
10 G Sep 28, 2025 Post an enquiry for this product
